348 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Spero Gets Fast Track Designation for SPR994, Shares Improve http://www.zacks.com/stock/news/368643/spero-gets-fast-track-designation-for-spr994-shares-improve?cid=CS-ZC-FT-368643 Apr 01, 2019 - Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.
The late Agnes Varda saluted by peers for her inventiveness and childlike spirit http://www.latimes.com/entertainment/movies/la-et-mn-agnes-varda-dead-reactions-20190329-story.html Mar 29, 2019 -

French director Agnès Varda, whose landmark films include “Cléo From 5 to 7” (1962) and “Vagabond” (1985), was saluted by her peers on Friday following her death at age 90.

She was a founding spirit of the French New Wave and a visionary creator, and filmmakers, film organizations and other creatives...

Company News For Mar 26, 2019 http://www.zacks.com/stock/news/364668/company-news-for-mar-26-2019?cid=CS-ZC--364668 Mar 26, 2019 - Companies In The News Are: BA, AGN, NKE, VIAB, T
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus http://www.zacks.com/stock/news/362572/zacks-market-edge-highlights-edwards-lifesciences-exact-sciences-aimmune-therapeutics-allergan-and-evolus?cid=CS-ZC-FT-362572 Mar 21, 2019 - Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle? https://www.fool.com/investing/2019/03/19/starboard-vs-bristol-myers-squibb-and-celgene-whol.aspx?source=iedfolrf0000001 Mar 19, 2019 - An activist investor made a strong argument for walking away from Celgene, but will investors listen?
Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients http://www.zacks.com/stock/news/361445/allergans-anti-infective-gets-fda-nod-for-pediatric-patients?cid=CS-ZC-FT-361445 Mar 19, 2019 - The FDA approves Allergan's (AGN) sNDA for the label expansion of its antibacterial medicine, Avycaz, to treat cUTI and cIAI in pediatric patients.
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others http://www.zacks.com/stock/news/359854/pharma-stock-roundup-regulatory-updates-from-mrk-pfe-jj-agn-others?cid=CS-ZC-FT-359854 Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Today's After-Hours News: Allergan and American Eagle Are Trading Lower https://www.fool.com/investing/2019/03/06/todays-after-hours-news-allergan-and-american-eagl.aspx?source=iedfolrf0000001 Mar 06, 2019 - Disappointing phase 3 drug results and a weaker-than-expected revenue outlook are weighing on these stocks.
J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression http://www.zacks.com/stock/news/357836/jjs-jnj-nasal-spray-spravato-gets-fda-nod-for-depression?cid=CS-ZC-FT-357836 Mar 06, 2019 - J&J (JNJ) gets FDA nod for its new nasal spray, Spravato (esketamine) for treatment-resistant depression
Okta (OKTA) to Report Q4 Earnings: How Are Things Shaping Up? http://www.zacks.com/stock/news/357603/okta-okta-to-report-q4-earnings-how-are-things-shaping-up?cid=CS-ZC-FT-357603 Mar 04, 2019 - Okta's (OKTA) fourth-quarter fiscal 2019 top-line is likely to benefit from its solid customer base despite higher expenses.

Pages: 123456789...35

<<<Page 4>